My sinuses have been bunged up for years. I'm constantly blowing my nose. I use nasal decongestants but those don't seem to ...

People with allergic fungal rhinosinusitis taking Dupixent (dupilumab) saw significant improvement in congestion and sinus ...

BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027 KT-621 BREADTH Phase 2b trial in asthma ongoing, with data expected in late-2027 Initiated dosing in KT-579 ...

The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week ...

By type, the subcutaneous immunotherapy segment held the highest share in the year 2023. Subcutaneous immunotherapy helps reduce allergy symptoms. It is known to offer sustained relief even after ...

Neurent Medical today announced positive findings from a randomized controlled trial evaluating its Neuromark system.

Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced the publication of positive results from its randomized controlled trial (RCT) evaluating the NEUROMARK® ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...

Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly ...

Early in 2026, Polyrizon Ltd. , a pre-clinical-stage biotechnology company developing intranasal protective solutions, ...

According to MarketsandMarkets, the Allergy Diagnostics Market is projected to grow from about USD 6.80 billion in 2026 to USD 10.77 billion ...